Cargando…

Re‐exposure to immunotherapy in metastatic colon cancer: A case report

Re‐exposure to immunotherapy in metastatic colorectal cancer may be indicated in selected patients that previously benefitted from immunotherapy with tolerable irAEs.

Detalles Bibliográficos
Autores principales: Hamre, Tonje Riise, Stougaard, Julie Kristine, Havelund, Birgitte Mayland, Jensen, Lars Henrik, Hansen, Torben Frøstrup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223690/
https://www.ncbi.nlm.nih.gov/pubmed/34194811
http://dx.doi.org/10.1002/ccr3.4349
_version_ 1783711744602931200
author Hamre, Tonje Riise
Stougaard, Julie Kristine
Havelund, Birgitte Mayland
Jensen, Lars Henrik
Hansen, Torben Frøstrup
author_facet Hamre, Tonje Riise
Stougaard, Julie Kristine
Havelund, Birgitte Mayland
Jensen, Lars Henrik
Hansen, Torben Frøstrup
author_sort Hamre, Tonje Riise
collection PubMed
description Re‐exposure to immunotherapy in metastatic colorectal cancer may be indicated in selected patients that previously benefitted from immunotherapy with tolerable irAEs.
format Online
Article
Text
id pubmed-8223690
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82236902021-06-29 Re‐exposure to immunotherapy in metastatic colon cancer: A case report Hamre, Tonje Riise Stougaard, Julie Kristine Havelund, Birgitte Mayland Jensen, Lars Henrik Hansen, Torben Frøstrup Clin Case Rep Case Reports Re‐exposure to immunotherapy in metastatic colorectal cancer may be indicated in selected patients that previously benefitted from immunotherapy with tolerable irAEs. John Wiley and Sons Inc. 2021-06-24 /pmc/articles/PMC8223690/ /pubmed/34194811 http://dx.doi.org/10.1002/ccr3.4349 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Hamre, Tonje Riise
Stougaard, Julie Kristine
Havelund, Birgitte Mayland
Jensen, Lars Henrik
Hansen, Torben Frøstrup
Re‐exposure to immunotherapy in metastatic colon cancer: A case report
title Re‐exposure to immunotherapy in metastatic colon cancer: A case report
title_full Re‐exposure to immunotherapy in metastatic colon cancer: A case report
title_fullStr Re‐exposure to immunotherapy in metastatic colon cancer: A case report
title_full_unstemmed Re‐exposure to immunotherapy in metastatic colon cancer: A case report
title_short Re‐exposure to immunotherapy in metastatic colon cancer: A case report
title_sort re‐exposure to immunotherapy in metastatic colon cancer: a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223690/
https://www.ncbi.nlm.nih.gov/pubmed/34194811
http://dx.doi.org/10.1002/ccr3.4349
work_keys_str_mv AT hamretonjeriise reexposuretoimmunotherapyinmetastaticcoloncanceracasereport
AT stougaardjuliekristine reexposuretoimmunotherapyinmetastaticcoloncanceracasereport
AT havelundbirgittemayland reexposuretoimmunotherapyinmetastaticcoloncanceracasereport
AT jensenlarshenrik reexposuretoimmunotherapyinmetastaticcoloncanceracasereport
AT hansentorbenfrøstrup reexposuretoimmunotherapyinmetastaticcoloncanceracasereport